Evommune (EVMN) Reiterated at Overweight by Cantor Fitzgerald on Tweaked OPEX Estimates

September 18, 2026 7:03 AM EDT Send to a Friend
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on Evommune Inc (NYSE: EVMN).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login